Rosenblatt Maintains Buy on Imax, Raises Price Target to $50
IMAX Corporation
IMAX Corporation IMAX | 0.00 |
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:
IMAX) with a Buy and raises the price target from $47 to $50.
Rosenblatt Maintains Buy on Imax, Raises Price Target to $50
IMAX Corporation IMAX | 0.00 |